|
|
 |
Trial Information
Summary: A Two-Week, Double Blind, Placebo Controlled, Randomized, Parallel Group, Efficay and Safety, Out Patient Trial With XXX in Patients With Chronic Primary Insomnia.
Patient Inclusion Criteria
- Able to provide informed consent
- Male or female, at least 18 years of age and the age of legal consent at the time of consent.
- Lifetime history of at least one bipolar manic or mixed episode
- Onset of Bipolar I depressive episode within ≥2 weeks and ≤6 months.
Patient Exclusion Criteria
- Attempted suicide within 3 months prior to Screening
- Pregnant or breast feeding at Screening or intend to become pregnant during the trial.
- History of seizures (except febrile seizures of childhood) or epilepsy or are taking an
anticonvulsant medication to prevent seizures.
- Had a seizure related to drug withdrawal within the past 6 months.
- History of significant cardiovascular disease or significant concurrent cardiovascular disease,
including uncontrolled hypertension
- Participated in a clinical trial with an investigational drug or device in the 30 days prior to
Screening.
|
Contact:
CRI Worldwide
130 White Horse Pike
Clementon, NJ 08021
Telephone: 877-993-2583 ext 213
Fax: 856-566-9701
Email:
|
|

If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.
This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: June 1, 2008 at 6:44:55 AM
|
 |
|